Clinical Research Laboratory, International Vaccine Institute, Seoul, Republic of Korea.
Vaccine Process Development, International Vaccine Institute, Seoul, Republic of Korea.
PLoS One. 2019 Mar 7;14(3):e0213507. doi: 10.1371/journal.pone.0213507. eCollection 2019.
Serum vibriocidal antibody assays have long been used to evaluate the immunogenicity of cholera vaccines formulated with killed whole-cell Vibrio cholerae. However, the antibody isotypes responsible for the serum vibriocidal activity are not fully characterized. In this study, we examined 20 clinical serum samples obtained from human subjects who had been vaccinated with a killed, whole-cell cholera vaccine and a positive control, human convalescent sera with high vibriocidal activity, to determine which isotype antibody is associated with the vibriocidal activity. Antibody isotypes from pooled convalescent sera were fractionated by size-exclusion column chromatography, and the major vibriocidal activity was detected in the IgM fraction. Depletion of IgM antibodies in the convalescent sera produced a significant (P<0.05) decrease in vibriocidal activity (16-fold decrease), whereas only a small change was observed with depletion of IgG or IgA. In addition, anti-LPS IgM antibody showed the highest correlation with vibriocidal activity (Spearman correlation coefficient r = 0.846) among antibody isotypes against heat-killed V. cholerae, lipopolysaccharide (LPS), or major outer membrane protein (Omp U), while total IgG, IgA, or IgM antibody level was not correlated with vibriocidal activity in the 20 human clinical serum samples. Furthermore, human convalescent sera significantly (P<0.001) inhibited the attachment of V. cholerae to HT-29, a human intestinal epithelial cell in vitro. Interestingly, IgM-depleted convalescent sera could not effectively inhibit bacterial adherence compared with non-depleted sera (P<0.05). Finally, bacterial adhesion was significantly inhibited by sera with high vibriocidal titer compared with low-titer sera (P = 0.014). Collectively, we demonstrated that anti-V. cholerae LPS IgM is highly correlated with serum vibriocidal activity and it could be a surrogate antibody isotype representing protective antibodies against V. cholerae.
血清杀弧菌抗体检测法长期以来一直被用于评估以杀死的全细胞霍乱弧菌为配方的霍乱疫苗的免疫原性。然而,负责血清杀弧菌活性的抗体同种型尚未完全表征。在这项研究中,我们检查了 20 份来自已接种杀死的全细胞霍乱疫苗的人类受试者的临床血清样本和一个阳性对照,即具有高杀弧菌活性的人恢复期血清,以确定哪种抗体同种型与杀弧菌活性相关。从混合恢复期血清中分离抗体同种型通过大小排阻柱色谱法进行,主要杀弧菌活性出现在 IgM 馏分中。在恢复期血清中耗尽 IgM 抗体可显著(P<0.05)降低杀弧菌活性(降低 16 倍),而耗尽 IgG 或 IgA 时仅观察到微小变化。此外,抗 LPS IgM 抗体与杀弧菌活性(Spearman 相关系数 r = 0.846)的相关性最高,而针对热杀死的霍乱弧菌、脂多糖(LPS)或主要外膜蛋白(Omp U)的抗体同种型,总 IgG、IgA 或 IgM 抗体水平与 20 个人类临床血清样本中的杀弧菌活性无关。此外,人恢复期血清可显著(P<0.001)抑制霍乱弧菌在体外附着于 HT-29,一种人肠上皮细胞。有趣的是,与未耗尽的血清相比,耗尽 IgM 的恢复期血清不能有效抑制细菌附着(P<0.05)。最后,与低滴度血清相比,高杀弧菌滴度的血清可显著抑制细菌粘附(P = 0.014)。总的来说,我们证明了抗霍乱弧菌 LPS IgM 与血清杀弧菌活性高度相关,它可能是代表针对霍乱弧菌的保护性抗体的替代抗体同种型。